Literature DB >> 19034695

The BLyS family: toward a molecular understanding of B cell homeostasis.

John F Treml1, Yi Hao, Jason E Stadanlick, Michael P Cancro.   

Abstract

The B Lymphocyte Stimulator (BLyS) family of ligands and receptors regulates humoral immunity by controlling B lymphocyte survival and differentiation. Herein, we review the ligands and receptors of this family, their biological functions, and the biochemical processes through which they operate. Pre-immune B lymphocytes rely on BLyS signaling for their survival, whereas antigen experienced B lymphocytes generally interact more avidly with a homologous cytokine, A Proliferation Inducing Ligand (APRIL). The molecular basis for signaling via the three BLyS family receptors reveals complex interplay with other B lymphocyte signaling systems, affording the integration of selective and homeostatic processes. As our understanding of this system advances, molecular targets for manipulating humoral immunity in both health and disease should be revealed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19034695      PMCID: PMC2654184          DOI: 10.1007/s12013-008-9036-1

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  173 in total

Review 1.  Signaling to NF-kappaB.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2004-09-15       Impact factor: 11.361

2.  Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras.

Authors:  D Nemazee; K Buerki
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Circulating T and B lymphocytes of the mouse. II. Lifespan.

Authors:  J Sprent; A Basten
Journal:  Cell Immunol       Date:  1973-04       Impact factor: 4.868

4.  Population dynamics of bone marrow B lymphocytes.

Authors:  D G Osmond
Journal:  Immunol Rev       Date:  1986-10       Impact factor: 12.988

5.  Act1, a negative regulator in CD40- and BAFF-mediated B cell survival.

Authors:  Youcun Qian; Jinzhong Qin; Grace Cui; Mayumi Naramura; E Charles Snow; Carl F Ware; Robert L Fairchild; Sidne A Omori; Robert C Rickert; Martin Scott; Brian L Kotzin; Xiaoxia Li
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

6.  The crystal structure of a proliferation-inducing ligand, APRIL.

Authors:  Heidi J A Wallweber; Deanne M Compaan; Melissa A Starovasnik; Sarah G Hymowitz
Journal:  J Mol Biol       Date:  2004-10-15       Impact factor: 5.469

Review 7.  Peripheral B lymphocyte tolerance.

Authors:  Amanda Gavin; Djemel Aït-Azzouzene; Annica Mårtensson; Bao Duong; Laurent Verkoczy; José Luis Vela; José Luis Skog; Patrick Skog; David Nemazee
Journal:  Keio J Med       Date:  2004-09

8.  Regulation of B-cell survival by BAFF-dependent PKCdelta-mediated nuclear signalling.

Authors:  Ingrid Mecklenbräuker; Susan L Kalled; Michael Leitges; Fabienne Mackay; Alexander Tarakhovsky
Journal:  Nature       Date:  2004-09-08       Impact factor: 49.962

9.  B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation.

Authors:  Svetlana Shulga-Morskaya; Max Dobles; Meghan E Walsh; Lai Guan Ng; Fabienne MacKay; Sambasiva P Rao; Susan L Kalled; Martin L Scott
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

10.  Most peripheral B cells in mice are ligand selected.

Authors:  H Gu; D Tarlinton; W Müller; K Rajewsky; I Förster
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

View more
  46 in total

Review 1.  B cells and transplantation tolerance.

Authors:  Allan D Kirk; Nicole A Turgeon; Neal N Iwakoshi
Journal:  Nat Rev Nephrol       Date:  2010-08-24       Impact factor: 28.314

Review 2.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

Review 3.  Translational Mini-Review Series on B Cell-Directed Therapies: The pathogenic role of B cells in autoantibody-associated autoimmune diseases--lessons from B cell-depletion therapy.

Authors:  M J Leandro; I de la Torre
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

4.  A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice.

Authors:  Yi Hao; Patrick O'Neill; Martin S Naradikian; Jean L Scholz; Michael P Cancro
Journal:  Blood       Date:  2011-05-11       Impact factor: 22.113

Review 5.  Systemic lupus erythematosus: Diagnosis and clinical management.

Authors:  Andrea Fava; Michelle Petri
Journal:  J Autoimmun       Date:  2018-11-16       Impact factor: 7.094

Review 6.  New roles for the BLyS/BAFF family in antigen-experienced B cell niches.

Authors:  Radhika Goenka; Jean L Scholz; Vishal J Sindhava; Michael P Cancro
Journal:  Cytokine Growth Factor Rev       Date:  2014-01-10       Impact factor: 7.638

Review 7.  Do RANKL inhibitors (denosumab) affect inflammation and immunity?

Authors:  S Ferrari-Lacraz; S Ferrari
Journal:  Osteoporos Int       Date:  2010-06-23       Impact factor: 4.507

Review 8.  Clinical targeting of the TNF and TNFR superfamilies.

Authors:  Michael Croft; Chris A Benedict; Carl F Ware
Journal:  Nat Rev Drug Discov       Date:  2013-01-21       Impact factor: 84.694

9.  Investigations of a rabbit (Oryctolagus cuniculus) model of systemic lupus erythematosus (SLE), BAFF and its receptors.

Authors:  Jiahui Yang; Richard Pospisil; Satyajit Ray; Jacqueline Milton; Rose G Mage
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

10.  Biological targets in the treatment of rheumatoid arthritis: a comprehensive review of current and in-development biological disease modifying anti-rheumatic drugs.

Authors:  Manil Kukar; Olga Petryna; Petros Efthimiou
Journal:  Biologics       Date:  2009-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.